Skin cancer drug approved by UK regulators

Roche’s skin cancer drug, Erivedge (vismodegib), has been approved by regulators to treat people with severe basal cell carcinoma (BCC).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news